The value of polymorphism + 3725G / C TLR4 gene as a marker of liver fibrosis progression in patients with chronic hepatitis C
KeywordsHCV, chronic hepatitis C, liver fibrosis, cirrhosis, TLR4 gene, viral load
As a rule, chronic hepatitis C is manifested by the development of successive stages of liver fibrosis with the formation of eventually cirrhosis and liver cancer. However, in some patients the fibrosis progresses slowly, while in others there is a rapid formation of cirrhosis, which causes high mortality among such patients. According to published data, despite a fairly large number of studies regarding liver cirrhosis in chronic hepatitis C, factors contributing to liver fibrogenesis have not been definitively determined. The available data are quite contradictory. In this article, we review studies have assessed the TLR4 + 3725G/C gene polymorphism as a factor that may influence the rate of fibrotic progression. The research will build new approach for avoiding fast fibrogenesis.
Chaiwiang, N., & Poyomtip, T. (2019). The associations between Toll-like receptor 4 gene polymorphisms and hepatitis C virus infection: a systematic review and meta-analysis. Bioscience reports, 39(2).
Collister, M., Ellison, C., Li, Q., Minuk, G. Y., Rempel, J. D., & Kung, S. K. (2019). The Influence of Hepatitis C Viral Loads on Natural Killer Cell Function. Gastroenterology research, 12(1), 8.
Erman, A., Krahn, M. D., Hansen, T., Wong, J., Bielecki, J. M., Feld, J. J., ... & Thein, H. H. (2019). Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update. BMJ open, 9(11).
Kucherenko, A. M., Moroz, L. V., Bevz, T. I., Bulavenko, V. I., Antypkin, Y. G., Berezenko, V. S., ... & Livshits, L. A. (2019). Investigation of rs11536889+ 3725G/C polymorphism of the TLR4 gene in patients with autoimmune and chronic viral hepatitis C. Cytology and Genetics, 53(4), 300-306.
Lu, M., Li, J., Rupp, L. B., Zhou, Y., Holmberg, S. D., Moorman, A. C., ... & Schmidt, M. A. (2018). Changing trends in complications of chronic hepatitis C. Liver International, 38(2), 239-247.
Mohamed, A. A., Elbedewy, T. A., El-Serafy, M., El-Toukhy, N., Ahmed, W., & El Din, Z. A. (2015). Hepatitis C virus: A global view. World journal of hepatology, 7(26), 2676.
Moroz, L. V., Bondaruk, I. Y., Popovich, A. A., & Kulias, S. N. (2019). Comparison of the diagnostic efficiency of various noninvasive methods for diagnosing liver fibrosis in patients with chronic viral hepatitis C. Journal of Education, Health and Sport, 9(6), 546-555.
Patra, T., Ray, R. B., & Ray, R. (2019). Strategies to circumvent host innate immune response by hepatitis C virus. Cells, 8(3), 274.
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A., & Cacciapuoti, C. (2016). Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World journal of gastroenterology, 22(34), 7824.
Yang, Y., Tu, Z. K., Liu, X. K., & Zhang, P. (2018). Mononuclear phagocyte system in hepatitis C virus infection. World journal of gastroenterology, 24(44), 4962.
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 60
Number of citations: 0